著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Ken Kato and Taroh Satoh and Kei Muro and Takaki Yoshikawa and Takao Tamura and Yasuo Hamamoto and Keisho Chin and Keiko Minashi and Masahiro Tsuda and Kensei Yamaguchi and Nozomu Machida and Taito Esaki and Masahiro Goto and Yoshito Komatsu and Takako Eguchi Nakajima and Naotoshi Sugimoto and Kazuhiro Yoshida and Eiji Oki and Tomohiro Nishina and Akihito Tsuji and Hirofumi Fujii and Kenji Kunieda and Soh Saitoh and Yasushi Omuro and Mizutomo Azuma and Yasuo Iwamoto and Keisei Taku and Sachio Fushida and Li-Tzong Chen and Yoon-Koo Kang and Narikazu Boku,"A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)",Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,14363291,Tokyo : Springer Japan,2019,22,2,344-354,https://cir.nii.ac.jp/crid/1524232504534792064,